GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ectin Research AB (XSAT:ECTIN B) » Definitions » Tariff Resilience Score

Ectin Research AB (XSAT:ECTIN B) Tariff Resilience Score : 0/10 (As of Jul. 05, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Ectin Research AB Tariff Resilience Score?

Ectin Research AB has the Tariff Resilience Score of 0, which implies that the company might have .

Ectin Research AB has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Ectin Research AB might have .

Ectin Research AB  (XSAT:ECTIN B) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Ectin Research AB Tariff Resilience Score Related Terms

Thank you for viewing the detailed overview of Ectin Research AB's Tariff Resilience Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Ectin Research AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ectin Research AB (XSAT:ECTIN B) » Definitions » Tariff Resilience Score
Comparable Companies
OSTO:QUIA XSAT:EUCI OSTO:LIDDS OSTO:PROMO OSTO:CLINE B OSTO:AMNI OSTO:REDW XSAT:ALTE OSTO:PHARM OSTO:DIABIO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
Pepparedsleden 1, Molndal, SWE, 431 83
Website
https://www.ectinresearch.com
Ectin Research AB is a pharmaceutical company developing a novel treatment that eliminates cancer tumors. Its drug candidate MFA-370 engages in the treatment of metastatic bladder cancer, and has also shown potential in other cancers such as breast, colorectal and prostate cancer cells.

Ectin Research AB Headlines

No Headlines